查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451546

儿科疫苗市场报告（按类型（多价、单价）、技术（结合疫苗、减毒活疫苗、灭活疫苗、亚基疫苗、类毒素等）、应用（传染病、癌症、过敏等）和地区2024 -2032

Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球儿科疫苗市场规模达370亿美元。展望未来， IMARC Group预计到2032年市场规模将达到703亿美元，2024-2032年复合年增长率（CAGR）为7.26%。疫苗接种计划的不断开展、对组合疫苗的日益关注以及製药公司和医疗保健组织之间为快速开发和分配疫苗而加强的合作伙伴关係是推动市场的一些主要因素。

儿科疫苗是一种刺激免疫系统辨识和对抗特定传染源（例如细菌或病毒）的医疗製剂。它们包含弱化或灭活形式的病原体或病原体的成分，促使免疫系统针对目标疾病形成防御机制。它们可以预防麻疹、小儿麻痹、百日咳、肝炎和流感。它们在被批准使用之前经过严格的测试和评估，以确保其安全性。它们可以防止可能导致儿童严重併发症或死亡的疾病传播。

目前，儿童脊髓灰质炎、结核病和疟疾等各种传染病和可能危及生命的疾病的日益增多正在推动市场的成长。除此之外，世界各地政府不断采取的旨在让儿童免疫预防可预防疾病的措施也促进了市场的成长。此外，疫苗储存和分配方法的技术不断进步，以改善医疗基础设施欠发达地区的供应链，这提供了良好的市场前景。除此之外，製药公司和医疗保健组织之间为快速开发和分销疫苗而加强的合作伙伴关係正在支持市场的成长。此外，世界各地为改善医疗保健服务而不断建设的诊所和医院也促进了市场的成长。

儿科疫苗市场趋势/驱动因素：

加强疫苗接种计画的实施

疫苗接种计划的持续实施显着提振了儿科疫苗市场。这些疫苗接种措施得到了政府和非政府组织的支持，在保障儿童的健康和福祉方面发挥关键作用。随着越来越多的儿童接受各种疾病的基本免疫接种，对儿科疫苗的需求也成比例增加。除此之外，以疾病预防为重点的疫苗接种计画正在减少儿童特定疾病的发生率。这随后会减轻医疗保健系统和家庭的负担，从而提高儿童及其照顾者的整体生活品质。此外，家长和医疗保健提供者对免疫接种重要性的认识不断提高，疫苗接种率也随之提高。

越来越关注组合疫苗

对组合疫苗的高度重视有助于儿科疫苗市场的积极发展。联合疫苗透过单一配方提供对多种疾病的保护，从而提供了一种策略性的免疫方法。这种方法简化了医疗保健提供者、护理人员和儿童等的疫苗接种过程，从而提高了依从性和疫苗覆盖率。此外，联合疫苗解决了疫苗犹豫和漏服可能性的挑战。由于儿童透过一次注射即可获得多种疾病的保护，因此疫苗接种的负担显着减轻。这鼓励家长遵守建议的疫苗接种计划，并有助于实现更高的全面免疫覆盖率。

新型疫苗的不断开发

新型疫苗的持续发展在推动儿科疫苗市场的积极成长方面发挥关键作用。专门针对儿童健康需求量身订製的新疫苗的出现有助于加强疾病预防、改善公共卫生结果并扩大市场机会。新型疫苗的开发也反映了疫苗技术和研究的进步。基因组学和生物资讯学等尖端研究方法使科学家能够更快、更准确地识别潜在的候选疫苗。这种加快的发现速度正在创造出有效且符合不断变化的流行病学情况的疫苗。此外，新型疫苗的持续发展正在刺激公共卫生组织、研究机构和疫苗製造商之间的合作。这些伙伴关係有助于及时推出新疫苗，并确保将其有效分发给儿科族群。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球儿科疫苗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 多价
    • 市场走向
    • 市场预测
  • 单价
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 共轭
    • 市场走向
    • 市场预测
  • 活衰减
    • 市场走向
    • 市场预测
  • 灭活
    • 市场走向
    • 市场预测
  • 亚基
    • 市场走向
    • 市场预测
  • 类毒素
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 传染病
    • 市场走向
    • 市场预测
  • 癌症
    • 市场走向
    • 市场预测
  • 过敏
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Bio-Med Private Limited
    • Daiichi Sankyo Company Limited
    • GSK plc
    • Indian Immunologicals Limited (National Dairy Development Board)
    • Merck & Co. Inc.
    • Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
    • Panacea Biotec Limited
    • Pfizer Inc.
    • Sanofi SA
    • Sinovac Biotech Ltd.
Product Code: SR112024A6230

The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032. The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.

At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.

Pediatric Vaccines Market Trends/Drivers:

Growing conduction of vaccination programs

The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.

Increasing focus on combination vaccines

The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.

Rising development of novel vaccines

The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.

Pediatric Vaccines Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pediatric vaccines market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, technology, and application.

Breakup by Type:

Multivalent

Monovalent

Multivalent dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes multivalent and monovalent. According to the report, multivalent represented the largest segment.

Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.

Breakup by Technology:

Conjugate

Live Attenuated

Inactivated

Subunit

Toxoid

Others

Conjugate holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes conjugate, live attenuated, inactivated, subunit, toxoid, and others. According to the report, conjugate accounted for the largest market share.

Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.

Breakup by Application:

Infectious Disease

Cancer

Allergy

Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes infectious disease, cancer, allergy, and others.

Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.

Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.

Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.

Competitive Landscape:

Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Bio-Med Private Limited

Daiichi Sankyo Company Limited

GSK plc

Indian Immunologicals Limited (National Dairy Development Board)

Merck & Co. Inc.

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)

Panacea Biotec Limited

Pfizer Inc.

Sanofi S.A.

Sinovac Biotech Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global pediatric vaccines market in 2023?
  • 2. What is the expected growth rate of the global pediatric vaccines market during 2024-2032?
  • 3. What are the key factors driving the global pediatric vaccines market?
  • 4. What has been the impact of COVID-19 on the global pediatric vaccines market?
  • 5. What is the breakup of the global pediatric vaccines market based on the type?
  • 6. What is the breakup of the global pediatric vaccines market based on the technology?
  • 7. What are the key regions in the global pediatric vaccines market?
  • 8. Who are the key players/companies in the global pediatric vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multivalent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Monovalent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Conjugate
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Toxoid
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Allergy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Med Private Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Daiichi Sankyo Company Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 GSK plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Panacea Biotec Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinovac Biotech Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
  • Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
  • Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pediatric Vaccines Market: Competitive Structure
  • Table 7: Global: Pediatric Vaccines Market: Key Players